Defitelio is administered through an intravenous (IV) infusion, meaning the medication is delivered directly into the bloodstream through a vein. It is typically given over a period of several hours, and the exact duration and frequency of the treatment depend on the patient’s condition and the doctor’s recommendations. The infusion is typically given in a hospital or healthcare facility where the patient can be monitored for any side effects or complications.
This medication should only be used under the supervision of a healthcare professional who can monitor the patient’s condition and response to treatment. The healthcare provider will adjust the dose and duration of treatment as necessary to ensure the best outcome.
Defitelio works by restoring normal blood flow in the liver and preventing further damage to blood vessels. The medication helps break down blood clots and reduces inflammation, which can help reduce the symptoms of VOD. By improving blood circulation in the liver, it can prevent the damage to the liver’s cells and tissues, supporting better recovery for patients undergoing stem cell transplants or chemotherapy.
One key aspect of how it works is by promoting the breaking down of the thickened blood inside the veins of the liver. This reduces clot formation, improving blood flow and reducing the risks of long-term damage that can occur with VOD.
Like any medication, Defitelio can cause side effects, though not everyone will experience them. Some common side effects may include:
- Bleeding or bruising easily
- Low blood pressure (hypotension)
- Swelling (edema)
- Nausea or vomiting
- Fever
- Rash
In some rare cases, more serious side effects can occur, such as allergic reactions, which may include symptoms like difficulty breathing, rash, or swelling of the face, lips, or throat. If any of these serious symptoms appear, immediate medical attention is required.
Patients with pre-existing liver or kidney problems may be at higher risk for certain side effects and should be closely monitored during treatment. Additionally, any issues related to bleeding or clotting should be addressed promptly by a healthcare provider.
Before using Defitelio, there are several important considerations to keep in mind:
- Liver or kidney problems: If you have a history of liver or kidney disease, inform your healthcare provider before starting treatment. This may affect how your body responds to the medication.
- Bleeding disorders: Defitelio may increase the risk of bleeding, so patients with bleeding disorders should be closely monitored during treatment.
- Pregnancy and breastfeeding: It is important to inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding, as the safety of Defitelio during pregnancy and breastfeeding has not been established.
- Allergic reactions: If you have had an allergic reaction to any medication in the past, especially blood thinners or contrast agents, let your doctor know before receiving this treatment.
The dosage of Defitelio depends on the patient’s weight and the severity of their condition. It is usually administered as an IV infusion, with the duration of treatment determined by the healthcare provider. The standard infusion time for each dose is around 2 hours, though the doctor may adjust this based on individual needs.
The medication is typically administered daily for a certain number of days, but the healthcare provider will decide the exact treatment course. Be sure to follow all instructions provided by your healthcare provider and attend any follow-up appointments to monitor progress.
Defitelio is available only through a prescription from a licensed healthcare provider. It is considered a specialized medication for treating VOD, which means it is generally administered in hospital or clinic settings where a healthcare professional can monitor its effects. Patients cannot obtain this medication over the counter, and it requires a healthcare provider’s oversight due to the potential for serious side effects and the need for careful dosing.